Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial
出版年份 2021 全文链接
标题
Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 33, Issue 3, Pages 310-320
出版商
Elsevier BV
发表日期
2021-12-01
DOI
10.1016/j.annonc.2021.11.014
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
- (2021) Martine Piccart et al. LANCET ONCOLOGY
- Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk
- (2020) Barbara Pistilli et al. JOURNAL OF CLINICAL ONCOLOGY
- The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype
- (2019) Iris Kramer et al. JNCI-Journal of the National Cancer Institute
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes
- (2019) Jamila Adra et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
- (2019) Martin Sjöström et al. CLINICAL CANCER RESEARCH
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx
- (2019) Fabrice Andre et al. JOURNAL OF CLINICAL ONCOLOGY
- Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
- (2019) H J Burstein et al. ANNALS OF ONCOLOGY
- Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis
- (2019) A R Ferreira et al. ANNALS OF ONCOLOGY
- Patterns of breast cancer relapse in accordance to biological subtype
- (2018) Atanas Ignatov et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01)
- (2018) Heather B. Neuman et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing side effects in adjuvant endocrine therapy for breast cancer
- (2018) Rosaria Condorelli et al. Expert Review of Anticancer Therapy
- Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial
- (2017) Martin Sjöström et al. JOURNAL OF CLINICAL ONCOLOGY
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
- (2017) Laura J. Esserman et al. JAMA Oncology
- Introduction to the Analysis of Survival Data in the Presence of Competing Risks
- (2016) Peter C. Austin et al. CIRCULATION
- Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer
- (2016) K.C. Aalders et al. EUROPEAN JOURNAL OF CANCER
- Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study
- (2016) Patricia A. Ganz et al. JOURNAL OF CLINICAL ONCOLOGY
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval
- (2015) Annemieke Witteveen et al. PLoS One
- Adherence to Endocrine Therapy in Breast Cancer Adjuvant and Prevention Settings
- (2014) R. T. Chlebowski et al. Cancer Prevention Research
- The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer
- (2014) Nirmala Pathmanathan et al. JOURNAL OF CLINICAL PATHOLOGY
- The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
- (2013) Peter C. Austin STATISTICS IN MEDICINE
- Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
- (2011) Nils D. Arvold et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Reducing the Risk of Distant Metastases: A Better End Point in Adjuvant Aromatase Inhibitor Breast Cancer Trials?
- (2008) Shou-Ching Tang CANCER INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started